[Coronavirus and COVID-19 : focus on a galopping pandemic]. / Coronavirus et COVID-19 : le point sur une pandémie galopante.

The international community is currently facing a pandemic of acute respiratory syndrome caused by a new coronavirus, SARS-CoV-2. This syndrome has been named COVID-19 for CoronaVIrus Disease 2019 by the World Health Organization. The starting point of the epidemic is the city of Wuhan (China), where the virus is said to have been transmitted from animals to humans before inter-human transmission. This is the third epidemic caused by a coronavirus after those of severe acute respiratory syndrome (SARS) in 2003 and Middle East respiratory syndrome (MERS) started in 2012. COVID-19 has rapidly spread to China and is currently spreading all over the world. The infection mainly affects patients over 40 years of age and mortality is increased in the presence of comorbidities. Children are pauci- or asymptomatic. The diagnosis is most often based on the detection of the viral genome in the nasopharynx by molecular biology methods. In the absence of specific anti-viral molecules, treatment is currently mainly symptomatic. It is clear that the COVID-19 pandemic is more difficult to control than what the first data suggested. The key strategy to SARS-CoV-2 is to limit its transmission. Preventive measures are mainly based on the application of adequate hand hygiene measures and disinfection of the environment, as well as measures of social distance aimed at limiting contacts in the population and protecting populations at risk.

La communauté internationale fait actuellement face à une pandémie de syndrome respiratoire aigu due à un nouveau coronavirus, le SARS-CoV-2. Ce syndrome a été nommé COVID-19 pour COronaVIrus Disease 2019 par l'Organisation Mondiale de la Santé. Le point de départ de l'épidémie est la ville de Wuhan (Chine), où le virus aurait été transmis de l'animal à l'homme préalablement à la transmission inter-humaine. Il s'agit de la 3ème épidé¬mie causée par un coronavirus après celles du syndrome respiratoire aigu sévère (SARS) en 2003 et du syndrome respiratoire du Moyen-Orient (MERS) débutée en 2012. Le COVID-19 s'est rapidement propagé en Chine et se répand actuellement à travers le monde entier. L'infection touche surtout les patients de plus de 40 ans et la mortalité est accrue en présence de comorbidités. Les enfants sont, quant à eux, pauci- ou asymptomatiques. Le diagnostic repose, le plus souvent, sur la détection du génome viral au niveau du nasopharynx par des méthodes de biologie moléculaire. En l'absence de molécules anti-virales spéci¬fiques, le traitement reste, à l'heure actuelle, principalement symptomatique. Force est de constater que la pandémie de COVID-19 est plus difficile à contrôler que ce que les premières données ne laissaient présager. L'élément clé face au SARS-CoV-2 est de limiter sa transmission. Les mesures de prévention reposent, principalement, sur l'application de mesures d'hygiène des mains adéquates et la désinfection de l'environnement, ainsi que sur des mesures de distance sociale visant à limiter les contacts dans la population et à protéger les populations à risque.

[Kingella kingae bone and joint infections]. / Arthrites à Kingella kingae chez l'enfant : à propos de six cas.

We report six cases of children with probable or confirmed Kingella kingae bone and joint infections (BJI) and discuss the role of this pathogen in the pediatric population. The advent of Polymerase Chain Reaction (PCR) led to the recognition of the importance of Kingella kingae in several human diseases, particularly in BJI affecting children aged 6 to 48 months. Kingella kingae infections in children have most often a good prognosis provided that the diagnosis is discussed, appropriate diagnostic methods are performed and effective antibiotics are prescribed.

Nous rapportons 6 cas probables ou confirmés d'infections ostéoarticulaires (IOA) à Kingella kingae et proposons une revue de l'implication de ce pathogène en pédiatrie. L'avènement de la PCR (Polymerase Chain Reaction) a mis en lumière son rôle dans diverses maladies humaines, en particulier les IOA chez les enfants âgés de 6 à 48 mois. Le pronostic des infections à Kingella kingae chez l'enfant est le plus souvent bon, pour autant que le diagnostic soit évoqué, que les méthodes diagnostiques adéquates soient utilisées et qu'une antibiothérapie appropriée soit instaurée.

[Multidisciplinary management of alveolar echinococcosis : Echino-Liege Working Group]. / Prise en charge multidisciplinaire de l'échinococcose alvéolaire : le groupe Echino-Liège.

Alveolar echinococcosis is a zoonotic disease due to the tapeworm Echinococcus multilocularis. The definitive host is the red fox. Until recently, Belgium was considered a country at very low risk for alveolar echinococcosis. However, recent studies carried out in southern Belgium have revealed, through post-mortem examination, high prevalences (up to 62 %) in foxes. Cats and dogs can act as definitive hosts. Human are accidentally infected by ingestion of food contaminated by the feces. After a long incubation period, invasive hepatic lesions may appear, as well as extra-hepatic lesions. The disease may be fatal. The diagnosis is based on imaging techniques, serology and nucleic acid detection in tissues. Early diagnosis may allow surgical removal of the lesion associated with at least 2 years of albendazole postoperative treatment. In case of contraindication to surgery, a long term treatment with albendazole is necessary. Liver transplantation is sometimes necessary. This article presents the epidemiologic, clinical, diagnostic and therapeutics features of this zoonotic disease.

L'échinococcose alvéolaire est une zoonose due à Echinococcus multilocaris, un cestode, dont l'hôte définitif est le renard roux (Vulpes vulpes). Jusqu'il y a peu, la Belgique était un pays considéré comme à très faible risque pour cette parasitose, mais de récentes autopsies de renards ont montré des prévalences élevées chez ceux-ci (pouvant dépasser les 60 %). Les chiens et les chats peuvent également être des hôtes définitifs. La transmission humaine (hôte accidentel) se fait principalement via la consommation d'aliments souillés par les déjections animales contaminées donnant, après une longue période d'incubation, des lésions hépatiques infiltrantes et, éventuellement, des atteintes extra-hépatiques pouvant être mortelles. Le diagnostic est fondé sur l'imagerie médicale couplée à des tests sérologiques et la PCR sur des tissus. La prise en charge curative est chirurgicale, lorsque la résection complète est possible. Elle est associée à un traitement de deux ans post-opératoire à base d'albendazole. En cas d'impossibilité de résection complète, un traitement au long cours par de l'albendazole est préconisé. Enfin, dans certains cas, une transplantation hépatique peut être envisagée. En raison de l'augmentation des cas autochtones rencontrés en Wallonie, un groupe spécialisé dans la prise en charge de l'échinococcose a été créé au sein de l'université de Liège. Cet article illustre les caractéristiques épidémiologiques, cliniques, diagnostiques et thérapeutiques de cette zoonose.

[Brain abcesses associated with a systemic infection by Nocardia Farcinica]. / Abcès cérébraux a Nocardia Farcinica dans le cadre d'une infection systémique.

The prevalence of nocardia infections is increasing because of both improved detection laboratory techniques and a higher number of immunosuppressed patients. We report the case of a patient with brain abcesses resulting from nocardia farcinica cerebral dissemination associated with lung infection, endocarditis and ocular lesions for which we suspected a similar origin. This case gives the opportunity to discuss the main issues of these infections and the current therapeutic guidelines.

La prévalence des infections à nocardia est en augmentation depuis plusieurs années en raison, d'une part, de l'amélioration des techniques de détection de ces germes en laboratoire et, d'autre part, d'un nombre accru de patients immunodéprimés. Nous rapportons ici l'histoire d'un patient porteur d'une infection multifocale à Nocardia Farcinica associant des abcès cérébraux, une infection pulmonaire, une endocardite et une atteinte ophtalmique. Ce cas permet de discuter les principales caractéristiques de ces infections, ainsi que les recommandations thérapeutiques actuelles.

[Miliary tuberculosis in a patient under adalimumab]. / Tuberculose miliaire chez une patiente sous adalimumab : cas clinique.

We describe a case of atypical miliary tuberculosis diagnosed by molecular testing in a patient suffering from psoriasis arthritis treated by adalimumab. Tuberculosis may have a non-classical presentation in patients under biological treatments. We briefly discuss the difficulties underlying the diagnosis and treatment of tuberculosis, especially in patients suffering from fever of unknown origin.

Nous rapportons un cas de tuberculose (TB) miliaire chez une patiente souffrant de polyarthrite psoriasique traitée par adalimumab. L'opportunité nous est ainsi donnée d'illustrer la possibilité de présentations atypiques, en particulier chez les patients traités par agents biologiques. Nous discutons brièvement, aussi, des difficultés inhérentes au diagnostic et au traitement de la tuberculose.

[Management of febrile neutropenia in cancer patients]. / Prise en charge de la neutropénie fébrile chez le patient cancéreux.

The incidence of cancer is raising and the treatments are increasingly aggressive. Consequently, general practitioners, emergency departments, hematologists and oncologists are regularly facing a severe side-effect of cytotoxic therapy, febrile neutropenia (FN). FN is a serious complication of chemotherapy because it can be quickly fatal and causes a temporary or definitive cessation of treatment. In this article, we summarize the latest recommendations for the management of patients with FN under anti-cancer treatments.

[Hooping cough in adults, think about it!]. / Coqueluche chez l'adulte, pensez-y!

We report the case of a 47 year old patient who had been suffering from persistent cough for more than three weeks. Patient coughed predominantly during night time, without fever. The amoxicillin-clavulanic acid initially prescribed was not effective. A series of complementary investigations were performed before serology finally identified Bordetella pertussis infection after two months of symptoms which improved slowly without evident benefit of macrolide treatment. The diagnosis of whooping cough was also established for the wife of the patient with fast resolution of the symptoms after rapid unset of treatment with macrolides.

Chronic hepatitis C infection in a patient with bone marrow hypoplasia.

Chronic hepatitis C virus (HCV) infection is associated with multifarious extra-hepatic manifestations; the most described and discussed being mixed cryoglobulinemia which is strongly related to B-cell lymphoproliferative disorders (LPDs). We present a case of chronic HCV infection and mixed cryoglobulinemia, with minimal liver involvement. The case is a 53-year-old patient who was diagnosed as having bone marrow hypoplasia at the age of three. She received several blood transfusions to normalize her haemoglobin. At the age of 31, she was diagnosed with rheumatoid arthritis on account of her diffuse joint pain and inflammation, elevated rheumatoid factor (RF) and Raynaud's phenomenon. Twenty years later, monoclonal gammopathy of IgG Lambda (one year later, changed to IgM Kappa) was detected during a routine examination. A bone marrow biopsy showed hypoplasia, Kappa positive B-lymphocytes and low-grade malignant lymphoma cells. PCR of the bone marrow aspirate was not contributory. No treatment was initiated owing to her poor bone marrow function and she is under regular follow-up.

[Syphilis in 2008: practical aspects and controversies]. / Syphilis en 2008: controverses et attitudes pratiques.

Rising incidence rate of syphilis is observed in economically advanced countries, particularly among homosexual men and subpopulation with low socioeconomic status. The various clinical presentations are divided into early and late stages, including neurosyphilis. The latter can occur during any stage of the disease, leading to the question "when to perform lumbar puncture", particularly in HIV positive patients. Penicillin continues to be the first-line therapy for all stages of syphilis. An alternative treatment should be considered as an exemption, after advice from a specialist. All patients require prolonged clinical and serological follow-up after treatment to rule out relapse or re-infection. The diagnosis of syphilis is an opportunity to search and treat other sexually transmitted diseases in patients and their sexual partner(s).

A case of giant cell arteritis associated with culture-proven Coxiella burnetii aortitis.

A case of proven Coxiella burnetii aortitis, possibly associated with giant cell arteritis (GCA), is reported. A 72-year-old man, who is a hunter, presented with weight loss, fever, jaw claudication, and hardened temporal arteries associated with a persistent inflammatory syndrome and arteritis of the whole aorta, including the brachiocephalic arteries, as seen on 18F-fluorodeoxyglucose positron emission tomography/computed tomography. The diagnosis of GCA was retained, and treatment with prednisolone was started. Given the aneurysm of the abdominal aorta, the patient underwent replacement of the abdominal aorta with an allograft. Histology showed intense chronic arteritis attributed to atherosclerosis with dissection. However, Coxiella burnetii infection was confirmed by serology and then by culture and molecular biology on the surgical specimen. A combination of hydroxychloroquine and doxycycline was added to tapered prednisolone and the outcome was favourable.

[New treatments of infectious diseases over the last ten years]. / Avancées thérapeutiques en pathologie infectieuse au cours de la dernière décennie.

This review focuses on new antibiotics, particularly for gram-positive infections, new antiretroviral drugs, new treatment of fungal infections and indications of miltefosine in the treatment of leishmaniasis.

[New approaches to the treatment of the HIV-infected patient]. / Nouvelles approches dans la prise en charge de l'infection à VIH.

HIV infection remains a major problem of public health in Belgium as well as globally. The number of new diagnosies of HIV infection in Belgium remains between two and three daily. Given the dramatic effect of antiretroviral therapy on the mortality due to HIV infection, the number of patients is constantly increasing. The different problems related to HIV care are also changing. Aging of the patients and chronic exposure to antiretroviral medications have induced new complications. We will present in this brief article several new experimental and clinical approaches in which our centre has participated during the last two years.

[A review about nephropathia epidemica]. / L'Hantavirose fait encore parler d'elle.

We propose a review of history, aetiology, physiopathology, clinical features, treatment and prevention of nephropathia epidemica (NE) which represents the only form of Hantavirus infection in Belgium.

[Alteration of bone metabolism in HIV-infected patients treated by HAART]. / Anomalies du métabolisme osseux chez les patients infectés par le HIV et traités par trithérapie.

For several years already, a growing number of studies reports modifications in the bone metabolism among HIV-infected patients. Some of these studies, published even before the use of HAART, involved the infection itself. With the experience already available as concerns HAART, antiretroviral treatments (ART) seem however to be called into question. Data are divergent yet. Some studies tend to invalidate the collected data about the harmful role of HAART and prove the absence of effect or even the beneficial action of ART on bone. Moreover, the three important classes of ART are implied, even if the proteases inhibitors are most commonly charged. Pathogenic mechanism remain hypothetical. While the impact on morbidity seems to be weak for the time being, long-term repercussions are still unknown, in particular when children are concerned. In such conditions, it appears difficult to set up coherent politics of screening, prevention and treatment. Nevertheless beyond the divergences, the multifactorial character of alteration of HIV-infected patient's bone metabolism seems to be undeniable. The identification of the different parameters should in the future clarify the situation and enable the publishing of exact criteria of screening, prevention and treatment.

A pauci-symptomatic case of documented Hantavirus (Puumala) infection in a patient under anti-TNF treatment.

We describe the case of an 18-yr-old male under anti-TNF treatment for Crohn's disease for more than 8 months. He developed fever and biological inflammatory syndrome without absolutely no accompanying sign or symptom or paraclinical abnormality despite extensive work-up performed in the context of his immunocompromised state. Symptoms disappeared after 10 days and a diagnosis of Puumala infection was made retrospectively on a serological basis. The case illustrates that anti-TNF treatment does not worsen the course of Puumala infection and could even be associated with a milder clinical picture.